SLC5A2 and infection: The higher incidence of genitourinary infections observed in this investigation, as well as in several studies in the literature, may be attributed to the propensity of SGLT2 inhibitors to heighten infection risk, particularly in women, by augmenting glucose excretion via urine [15,16].